Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

Clinical trial NCT05927558 · COMPLETED

Trial details

NCT number: NCT05927558
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Study type: OBSERVATIONAL

B-cell Non Hodgkin Lymphoma Relapse Refractory Lymphoma

Start date: 2023-12-22
Primary completion: 2026-06-24
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.